Biomarkers to predict wound healing: The future of complex war wound management

Plastic and Reconstructive Surgery

Volumn 127, Issue SUPPL. 1 S, 2011, Pages

  Hahm, George ^a   Glaser, Jacob J ^a   Elster, Eric A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

HUMAN; INJURY; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PREDICTIVE VALUE; PROGNOSIS; REVIEW; WAR; WOUND HEALING;

BIOLOGICAL MARKERS; HUMANS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; WAR; WOUND HEALING; WOUNDS AND INJURIES;

EID: 78651270133     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0b013e3181fbe291     Document Type: Article

References (25)

1. Ovington LG. Advances in wound dressings. Clin Dermatol. 2007;25:33-38.
2. Broughton G II, Janis JE, Attinger CE. The basic science of wound healing. Plast Reconstr Surg. 2006;117(Suppl): 12S-34S.
3. Baker CC. Epidemiology of trauma: The civilian perspective. Ann Emerg Med. 1986;15:1389-1391.
4. Champion HR, Bellamy RF, Roberts CP, Leppaniemi A. A profile of combat injury. J Trauma 2003;54(Suppl):S13-S19.
5. Petersen K, Riddle MS, Danko JR, et al. Trauma-related infections in battlefield casualties from Iraq. Ann Surg. 2007; 245:803-811.
6. National Transportation Data Bank Report 2009. Available at: http://www.facs.org/trauma/ntdb/ntdbannualreport2009. pdf. Accessed November 3, 2010.
7. Owens B, Kragh J, Wenke J, Macaitis J, Wade C, Holcomb J. Combat wounds in operation Iraqi Freedom and Operation Enduring Freedom. J Trauma 2008;64:295-299.
8. Beebe G, Debakey M. Death from wounding. In: Battle Casualties. Springfield, Ill: Charles C Thomas; 1952:74-147.
9. Reister F. Battle Casualties and Medical Statistics: US Army Experience in the Korean War. Washington, DC: The Surgeon General, Department of the Army; 1973.
10. Hardaway R. Viet Nam wound analysis. J Trauma 1978;18: 635-643.
11. Bellamy R, Zajtchuk R. Assessing the effectiveness of conventional weapons. In: Conventional Warfare: Ballistics, Blast, and Burn Injuries. Washington, DC: Office of the Surgeon General; 1991:53-82.
12. Covey RD. Blast and fragment injuries of the musculoskeletal system. J Bone Joint Surg (Am.) 2002;84:1221-1234.
13. Bellamy R. Combat trauma overview. In: Textbook of Military Medicine, Anesthesia and Perioperative Care of the Combat Casualty. Falls Church, Va: Office of the Surgeon General, United States Army; 1995:1-42.
14. Nobre V, Herbarth S, Graf JD, Rohner P, Pugin J. Use of procalcitonin to shorten antibiotic duration in septic patients: A randomized trial. Am J Respir Crit Care Med. 2008; 177:498-505.
15. Greidanus NV, Masri BA, Garbuz DS, et al. Use of erythrocyte sedimentation rate and C-reactive protein level to diagnose infection before revision total knee arthroplasty. J Bone Joint Surg (Am.) 2007;89:1409-1416.
16. Yager DR, Kulina RA, Gilman LA. Wound fluids: A window into the wound environment? Int J Low Extrem Wounds 2007; 6:262-272.
17. Beidler SK, Douillet CD, Berndt DF, Keagy BA, Rich PB, Marston WA. Multiplexed analysis of matrix metalloproteinases in leg ulcer tissue of patients with chronic venous insufficiency before and after compression therapy. Wound Repair Regen. 2008;16:642-648.
18. Utz ER, Elster EA, Tadaki DK, et al. Metalloproteinase expression is associated with traumatic wound failure. J Surg Res. 2010;159:633-639.
19. Armstrong DG, Jude EB. The role of matrix metalloproteinases in wound healing. J Am Podiatr Med Assoc. 2002;92:12-18.
20. Gill SE, Parks WC. Metalloproteinases and their inhibitors: Regulators of wound healing. In J Biochem Cell Biol. 2008;40: 1334-1347.
21. Ladwig GP, Robson MC, Liu R, Kuhn MA, Muir DF, Schultz GS. Ratios of activated matrix metalloproteinase-9 to tissue inhibitor of matrix metalloproteinase-1 in wound fluids are inversely correlated with healing of pressure ulcers. Wound Repair Regen. 2002;10:26-37.
22. Norgauer J, Hildenbrand T, Idzako M, et al. Elevated expression of extracellular matrix metalloproteinase inducer (CD 147) and membrane-type matrix metalloproteinases in venous leg ulcers. Br J Dermatol. 2002;147:1180-1186.
23. Mwaura B, Mahendran B, Hynes N, et al. The impact of differential expression of extracellular matrix metalloproteinase inducer, matrix metalloproteinase-2, tissue inhibitor of matrix metalloproteinase-2 and PDGF-AA on the chronicity of venous leg ulcers. Eur J Vasc Endovasc Surg. 2006; 31:306-310.
24. Forsberg JA, Elster EA, Andersen RC, et al. Correlation of procalcitonin and cytokine expression with dehiscence of wartime extremity wounds. J Bone Joint Surg (Am.) 2008;90: 580-588.
25. Hawksworth JS, Stojadinovic A, Gage FA, et al. Inflammatory biomarkers in combat wound healing. Ann Surg. 2009;250: 1002-1007.